Causal Relationship Between Dry Eye and Accommodative Spasm

November 3, 2021 updated by: Lin-Chin Mai, Far Eastern Memorial Hospital
To investigate the causal relationship of Sicca dry eye patients with presbyopic refractive error and accommodative spasm.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Detailed Description

Dry eye is a disease of the ocular surface. Severe dry eye produce symptom of discomfort in and around the eye that drastically affect life quality of the patient. OSDI index is retrieve from a questionnaire specific for these dry eye symptoms, it is an internationally accepted level to reveal the severity of Dry eye disease. One part of the symptom is pain and soreness around the eye. Hyperalgesia is an increase response to a stressful/ noxious stimulus whereas allodynia is a painful response to a normally innocuous stimulus. Our hypothesis state that Sicca Dry eye upregulated inflammatory cytokine in the eye has pre-sensitized the nociceptor nerve fiber in the cornea and orbit, therefore the normally innocuous effort of accommodation and ciliary muscle contraction produce intolerable retro-orbital eye pain, which drives the patient to seek medical attention, on presentations these patient show an elevated OSDI and Pain Index (PI).

Study Type

Observational

Enrollment (Anticipated)

200

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

  • Name: Elsa LC Mai, MPH, Dr.
  • Phone Number: 4238 886-89667000
  • Email: elsamai@gmail.com

Study Locations

      • New Taipei City, Taiwan, 220
        • Recruiting
        • Far Eastern Memorial Hospital
        • Contact:
          • Lin-Chin Elsa Mai, Dr.
          • Phone Number: 4271 +886-2-8966-7000
          • Email: elsamai@gmail.com
        • Principal Investigator:
          • Lin-Chin Elsa Mai, Dr.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 99 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Asian population with dry eye

Description

Inclusion Criteria:

- dry eye

Exclusion Criteria:

  • under 20 year old

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
dry eye with presbyopia
dry eye with presbyopia , Intervention : glasses prescrubed
fogging for glasses for far and intermediate
dry eye with presbyopia without glasses use
no glasses use
fogging for glasses for far and intermediate

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Improve of dry eye / OSDI
Time Frame: 30 days
OSDI improve
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Elsa LC MAI, MPH, Dr., Far Eastern Memorial Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 5, 2021

Primary Completion (Anticipated)

July 20, 2024

Study Completion (Anticipated)

October 15, 2025

Study Registration Dates

First Submitted

November 3, 2021

First Submitted That Met QC Criteria

November 3, 2021

First Posted (Actual)

November 15, 2021

Study Record Updates

Last Update Posted (Actual)

November 15, 2021

Last Update Submitted That Met QC Criteria

November 3, 2021

Last Verified

November 1, 2021

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dry Eye

Clinical Trials on presbyopia glasses

3
Subscribe